The big winners of the tech wreck are biopharma stocks
Summary
Major pharmaceutical corporations are experiencing unprecedented market success while the technology sector faces a significant downturn. Share values for several prominent drug developers continue to reach all-time highs during this period of industry divergence.
The shares of large drugmakers like Lilly, Gilead and J&J keep hitting record highs.
Source: Read the full story at MarketWatch.com - Top Stories
Disclaimer: This content is for informational and educational purposes only and is not financial, investment or trading advice. Tech & Money Press is not a registered investment adviser or broker-dealer. Trading stocks, options and crypto involves substantial risk, including the loss of your entire investment. Do your own research and consult a licensed professional before making any financial decision. The authors may hold positions in the securities mentioned. News summaries are written with AI assistance from the original publisher's report and may contain errors; always check the original source. Full disclaimer.